Scarica l'app Stockscreener
4.55
4.01%
-0.19
Dopo l'orario di chiusura:
4.50
-0.05
-1.10%
Precedente Chiudi:
$4.74
Aprire:
$4.9
Volume 24 ore:
287.14K
Relative Volume:
1.74
Capitalizzazione di mercato:
$14.39M
Reddito:
-
Utile/perdita netta:
$-21.21M
Rapporto P/E:
-0.1396
EPS:
-32.6
Flusso di cassa netto:
$-16.86M
1 W Prestazione:
-10.78%
1M Prestazione:
-8.63%
6M Prestazione:
+13.35%
1 anno Prestazione:
-87.19%
Intervallo 1D:
$4.37
$4.90
Intervallo di 1 settimana:
$4.37
$5.15
Portata 52W:
$1.8001
$58.32
Cingulate Inc Stock (CING) Company Profile
Nome
Cingulate Inc
Settore
Industria
Telefono
(913) 942-2300
Indirizzo
1901 W. 47TH PLACE, KANSAS CITY
Confronta CING con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
4.55 | 14.39M | 0 | -21.21M | -16.86M | -32.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | ROTH MKM | Buy |
| 2023-12-22 | Downgrade | Laidlaw | Buy → Hold |
Cingulate Inc Borsa (CING) Ultime notizie
Cingulate stock price target raised to $20 at H.C. Wainwright By Investing.com - Investing.com South Africa
Cingulate stock price target raised to $20 at H.C. Wainwright - Investing.com India
Meta Platforms To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Public company CEO concludes case alleging aggravated domestic battery - The Business Journals
Cingulate Inc. adjusts executive compensation - Investing.com India
Cingulate Inc. adjusts executive compensation By Investing.com - Investing.com UK
Jane Street Group LLC Invests $106,000 in Cingulate Inc. (NASDAQ:CING) - Defense World
Cingulate stock rated Buy by Roth/MKM, anticipates $1.6B sales potential - Investing.com Canada
Cingulate (NASDAQ:CING) Coverage Initiated at Roth Mkm - Defense World
Roth Capital Upgrades Cingulate (NASDAQ:CING) to “Strong-Buy” - Defense World
Roth MKM Initiates Coverage of Cingulate (CING) with Buy Recommendation - MSN
CINGWCingulate Inc. Warrants Latest Stock News & Market Updates - StockTitan
Cingulate Inc Completes Key FDA Study for ADHD Drug - TipRanks
Final Study Completed for Cingulate’s Lead Asset CTx-1301 - GlobeNewswire
Cingulate Completes Final FDA Study for Once-Daily ADHD Drug CTx-1301 with Zero Safety Issues - StockTitan
Cingulate Inc. Enters into Note Purchase Agreement with Streeterville Capital, LLC - Defense World
Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval - The Business Journals
Cingulate Inc Secures $5M Financing for Strategic Growth - Yahoo Finance
Cingulate Inc. announced that it has received $5 million in funding - Marketscreener.com
Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000 - GlobeNewswire
Cingulate Secures $5M Financing Deal to Advance CTx-1301 Drug Development Through 2025 - StockTitan
Cingulate (NASDAQ:CING) Upgraded at Maxim Group - Defense World
U.S. Stock market top gainers: Binah Capital Group gains +107.02%, Aligos Therapeutics surges by 42.84% in mid day trading - Business Upturn
Cingulate Inc. Announces Third Quarter Financial Results and Clinical Update - Defense World
Cingulate Inc (CING) Quarterly 10-Q Report - Quartz
CINGCingulate Inc. Latest Stock News & Market Updates - StockTitan
Cingulate reports Q3 net loss $3.2M vs. $5.98M last year - TipRanks
Cingulate Reports Third Quarter 2024 Financial - GlobeNewswire
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market - StockTitan
Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - The Manila Times
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - GlobeNewswire
Cingulate secures funding to extend operations into Q2 2025 By Investing.com - Investing.com South Africa
SEC Form 424B3 filed by Cingulate Inc. - Quantisnow
Cingulate secures funding to extend operations into Q2 2025 - Investing.com India
Cingulate Inc Files for 1.5M Share Offering by Selling Stockholders - Investing.com Canada
Cingulate Inc. CEO faces domestic battery charge - Investing.com India
Cingulate Inc. CEO faces domestic battery charge By Investing.com - Investing.com South Africa
KC-area public company CEO faces charges for aggravated domestic battery - Kansas City Business Journal
Cingulate files to sell 1.5M shares of common stock for holders - MSN
Will Ciena's New 1.6 Tb/s Coherent Pluggable Solution Drive Top Line? - Zacks Investment Research
Concentrix Corp (CNXC) Q3 2024: Everything You Need to Know Ahea - GuruFocus.com
Cettire shares skyrocket - Finance News Network
Cettire gets auditor’s tick of approval, adding $247m to valuation - The Australian Financial Review
Stock of the day: Cettire - IG
Ciena Stock Goes to Buy From Sell at Citi. Here’s Why. - Barron's
Why Ciena Stock Popped 5% on Monday - The Motley Fool
Double-Upgrade Pushes Ciena Stock Near Record Highs - Schaeffers Research
Citi upgrades Ciena, shares rise in pre-market trade By Investing.com - Investing.com Canada
9 Analysts Assess Ciena: What You Need To Know - Benzinga
Ciena Unveils 1.6 Tb/s Coherent Pluggable Solution for Hyperscale Cloud Providers' Capacity Surge - Marketscreener.com
Ciena's stock rises after Citi double upgrades to Buy (NYSE:CIEN) - Seeking Alpha
Cingulate Inc Azioni (CING) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.49%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):